WealthGarden F.S.’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Buy
1,010
+43
+4% +$43.9K 0.69% 44
2026
Q1
$889K Sell
967
-72
-7% -$73K 0.61% 56
2025
Q4
$1.1M Sell
1,039
-89
-8% -$85.1K 0.73% 40
2025
Q3
$913K Sell
1,128
-169
-13% -$126K 0.65% 46
2025
Q2
$960K Sell
1,297
-3
-0.2% -$2.33K 0.8% 39
2025
Q1
$1.07M Buy
1,300
+17
+1% +$14.1K 1.03% 30
2024
Q4
$990K Sell
1,283
-9
-0.7% -$7.45K 0.93% 34
2024
Q3
$1.14M Buy
1,292
+151
+13% +$136K 1.11% 31
2024
Q2
$1.03M Buy
+1,141
New +$913K 1.09% 27

Other funds holding LLY

WealthGarden F.S.'s LLY Position: Q2 2026 in Review

WealthGarden F.S. increased its Eli Lilly (LLY) stake by 4.4% in Q2 2026, buying an estimated $43.9K and bringing the position to 1,010 shares worth $1.21M. The position accounts for 0.69% of the portfolio, ranked #44.

WealthGarden F.S. first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • WealthGarden F.S. held 1,010 shares of Eli Lilly worth $1.21M as of Q2 2026.
  • WealthGarden F.S. bought 43 Eli Lilly shares in Q2 2026, an estimated $43.9K.
  • Eli Lilly made up 0.69% of WealthGarden F.S.'s portfolio in Q2 2026, its #44 holding.
  • WealthGarden F.S. first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
  • 2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on WealthGarden F.S.'s 13F filing for Q2 2026, filed 31 Jul 2026.